Endocrinol Metab.  2014 Dec;29(4):441-442. 10.3803/EnM.2014.29.4.441.

Subclinical Cushing's Syndrome and Metabolic Disorder

• Bae JC

• KMID: 2384239
• DOI: http://doi.org/10.3803/EnM.2014.29.4.441

Abstract

No abstract available.

MeSH Terms

Cushing Syndrome*

Reference

1. Terzolo M, Pia A, Reimondo G. Subclinical Cushing's syndrome: definition and management. Clin Endocrinol (Oxf). 2012; 76:12–18.

2. Kim BY, Chun AR, Kim KJ, Jung CH, Kang SK, Mok JO, Kim CH. Clinical characteristics and metabolic features of patients with adrenal incidentalomas with or without subclinical Cushing's syndrome. Endocrinol Metab. 2014; 29:457–463.

3. Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP. Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens). 2009; 8:163–184.

4. Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab. 2011; 96:1223–1236.

5. Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014; 2:396–405.

6. Anagnostis P, Karras SN, Athyros VG, Mikhailidis DP, Karagiannis A. Subclinical Cushing's syndrome and cardiovascular disease. Lancet Diabetes Endocrinol. 2014; 2:361.